Rome V global epidemiology survey validates prevalence of gut-brain interaction disorders.

The Rome V global prevalence study, published in Gut (BMJ), found that the prevalence rates for disorders of gut–brain interaction (DGBI) are consistent with previous Rome IV findings, reaffirming their high global burden. The survey also introduced prevalence rates for two new DGBI: abdominal migraine (5.1%) and inability to belch syndrome (1.4%).